ADAMTS13 and blood coagulation disease: The results of this study highlight reduction in ADAMTS-13, platelet aggregation and decline and endotoxemia as key events in the evolution of the coagulopathy of ALI and emphasises the importance of global assessments of coagulation status in ALI/ALF and the use of blood products on an “on-demand” basis.